Structure

Physi-Chem Properties

Molecular Weight:  504.21
Volume:  519.821
LogP:  7.667
LogD:  4.596
LogS:  -3.027
# Rotatable Bonds:  4
TPSA:  105.45
# H-Bond Aceptor:  7
# H-Bond Donor:  3
# Rings:  5
# Heavy Atoms:  7

MedChem Properties

QED Drug-Likeness Score:  0.459
Synthetic Accessibility Score:  4.576
Fsp3:  0.367
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.811
MDCK Permeability:  1.7457708963775076e-05
Pgp-inhibitor:  0.96
Pgp-substrate:  0.082
Human Intestinal Absorption (HIA):  0.422
20% Bioavailability (F20%):  0.761
30% Bioavailability (F30%):  0.06

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.011
Plasma Protein Binding (PPB):  88.16790008544922%
Volume Distribution (VD):  1.086
Pgp-substrate:  10.984176635742188%

ADMET: Metabolism

CYP1A2-inhibitor:  0.358
CYP1A2-substrate:  0.202
CYP2C19-inhibitor:  0.793
CYP2C19-substrate:  0.381
CYP2C9-inhibitor:  0.812
CYP2C9-substrate:  0.389
CYP2D6-inhibitor:  0.89
CYP2D6-substrate:  0.16
CYP3A4-inhibitor:  0.63
CYP3A4-substrate:  0.46

ADMET: Excretion

Clearance (CL):  8.217
Half-life (T1/2):  0.059

ADMET: Toxicity

hERG Blockers:  0.085
Human Hepatotoxicity (H-HT):  0.976
Drug-inuced Liver Injury (DILI):  0.921
AMES Toxicity:  0.114
Rat Oral Acute Toxicity:  0.957
Maximum Recommended Daily Dose:  0.86
Skin Sensitization:  0.586
Carcinogencity:  0.832
Eye Corrosion:  0.003
Eye Irritation:  0.054
Respiratory Toxicity:  0.898

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC172687

Natural Product ID:  NPC172687
Common Name*:   Sorocein D
IUPAC Name:   n.a.
Synonyms:   Sorocein D
Standard InCHIKey:  BSEWSLOUHTTXHH-LOYHVIPDSA-N
Standard InCHI:  InChI=1S/C30H32O7/c1-16(2)7-8-18-21(31)10-9-20-26(18)37-30(34)27(33)24-23(36-29(20,30)14-11-17(3)4)15-22-19(25(24)32)12-13-28(5,6)35-22/h7,9-13,15,31-32,34H,8,14H2,1-6H3/t29-,30-/m1/s1
SMILES:  CC(=CC[C@@]12Oc3cc4OC(C)(C)C=Cc4c(c3C(=O)[C@@]2(O)Oc2c1ccc(c2CC=C(C)C)O)O)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL517862
PubChem CID:   44559965
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0000123] Benzopyrans
        • [CHEMONTID:0003410] 1-benzopyrans
          • [CHEMONTID:0003543] Pyranochromenes

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO9402 Morus mongolica Species Moraceae Eukaryota n.a. n.a. n.a. PMID[11429996]
NPO9402 Morus mongolica Species Moraceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO25003 Sorocea bonplandii Species Moraceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO9402 Morus mongolica Species Moraceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO9402 Morus mongolica Species Moraceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO8038 Pachliopta aristolochiae Species Papilionidae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO25003 Sorocea bonplandii Species Moraceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO2322 Oryctes nevadensis Species Solanaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO9402 Morus mongolica Species Moraceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT924 Cell Line HSC-2 Homo sapiens CC50 = 190000.0 nM PMID[522889]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. CC50 = 120000.0 nM PMID[522889]
NPT27 Others Unspecified CC50 = 270000.0 nM PMID[522889]
NPT27 Others Unspecified Ratio = 1.4 n.a. PMID[522889]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC172687 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9934 High Similarity NPC264932
0.9934 High Similarity NPC311574
0.9868 High Similarity NPC210048
0.9868 High Similarity NPC161650
0.9371 High Similarity NPC292233
0.9351 High Similarity NPC476169
0.9286 High Similarity NPC209760
0.9286 High Similarity NPC100134
0.9286 High Similarity NPC311579
0.9286 High Similarity NPC236756
0.9259 High Similarity NPC73899
0.9259 High Similarity NPC147363
0.9259 High Similarity NPC17105
0.9259 High Similarity NPC474276
0.9236 High Similarity NPC306978
0.9226 High Similarity NPC304207
0.9226 High Similarity NPC48579
0.9226 High Similarity NPC217706
0.9226 High Similarity NPC207809
0.9226 High Similarity NPC469934
0.9226 High Similarity NPC259710
0.9221 High Similarity NPC210597
0.9211 High Similarity NPC296869
0.9182 High Similarity NPC66087
0.9182 High Similarity NPC183672
0.9182 High Similarity NPC179198
0.9182 High Similarity NPC278419
0.9161 High Similarity NPC248793
0.9161 High Similarity NPC180301
0.9156 High Similarity NPC471675
0.9156 High Similarity NPC472636
0.9145 High Similarity NPC166757
0.9145 High Similarity NPC14001
0.9119 High Similarity NPC131745
0.9119 High Similarity NPC150164
0.9119 High Similarity NPC93215
0.9103 High Similarity NPC304745
0.9103 High Similarity NPC111341
0.9103 High Similarity NPC471116
0.9097 High Similarity NPC473996
0.9097 High Similarity NPC477957
0.9097 High Similarity NPC476238
0.9097 High Similarity NPC31627
0.9097 High Similarity NPC142527
0.9097 High Similarity NPC138288
0.9097 High Similarity NPC327269
0.9085 High Similarity NPC244407
0.9079 High Similarity NPC220418
0.9079 High Similarity NPC5820
0.9079 High Similarity NPC178343
0.9079 High Similarity NPC306488
0.9079 High Similarity NPC124729
0.9074 High Similarity NPC5319
0.9073 High Similarity NPC9117
0.9073 High Similarity NPC293053
0.9073 High Similarity NPC24821
0.9073 High Similarity NPC219915
0.9073 High Similarity NPC212932
0.9073 High Similarity NPC190637
0.9045 High Similarity NPC20530
0.9045 High Similarity NPC215917
0.9045 High Similarity NPC10754
0.9045 High Similarity NPC146636
0.9038 High Similarity NPC268193
0.9038 High Similarity NPC7989
0.9038 High Similarity NPC223701
0.9038 High Similarity NPC293286
0.9038 High Similarity NPC472583
0.9032 High Similarity NPC262039
0.9032 High Similarity NPC262038
0.9032 High Similarity NPC471229
0.9032 High Similarity NPC471677
0.9032 High Similarity NPC319910
0.9032 High Similarity NPC278476
0.9032 High Similarity NPC254412
0.9032 High Similarity NPC472580
0.9026 High Similarity NPC277032
0.902 High Similarity NPC472918
0.9018 High Similarity NPC287884
0.9018 High Similarity NPC8704
0.9013 High Similarity NPC71210
0.9013 High Similarity NPC273538
0.9013 High Similarity NPC216538
0.9013 High Similarity NPC326500
0.9007 High Similarity NPC200694
0.9007 High Similarity NPC473042
0.9006 High Similarity NPC72016
0.9 High Similarity NPC259834
0.8988 High Similarity NPC106700
0.8987 High Similarity NPC237418
0.8981 High Similarity NPC477958
0.8981 High Similarity NPC275575
0.8981 High Similarity NPC108937
0.8981 High Similarity NPC279218
0.8974 High Similarity NPC161881
0.8974 High Similarity NPC244583
0.8974 High Similarity NPC150123
0.8974 High Similarity NPC45934
0.8974 High Similarity NPC10807
0.8974 High Similarity NPC35567
0.8974 High Similarity NPC217149
0.8974 High Similarity NPC475790
0.8974 High Similarity NPC285623
0.8974 High Similarity NPC171651
0.8974 High Similarity NPC56232
0.8974 High Similarity NPC243171
0.8974 High Similarity NPC216035
0.8968 High Similarity NPC267117
0.8968 High Similarity NPC471984
0.8968 High Similarity NPC29777
0.8968 High Similarity NPC105136
0.8968 High Similarity NPC471115
0.8968 High Similarity NPC472421
0.8947 High Similarity NPC38219
0.8947 High Similarity NPC158874
0.8944 High Similarity NPC124155
0.8944 High Similarity NPC257566
0.894 High Similarity NPC310128
0.8931 High Similarity NPC320283
0.8931 High Similarity NPC472459
0.8931 High Similarity NPC111929
0.8931 High Similarity NPC125969
0.8931 High Similarity NPC470607
0.8931 High Similarity NPC41121
0.8924 High Similarity NPC475797
0.8924 High Similarity NPC109967
0.8924 High Similarity NPC469936
0.8924 High Similarity NPC78554
0.8924 High Similarity NPC474609
0.8924 High Similarity NPC474738
0.8924 High Similarity NPC129053
0.8924 High Similarity NPC321372
0.8917 High Similarity NPC469405
0.8917 High Similarity NPC20907
0.8917 High Similarity NPC88983
0.8917 High Similarity NPC203080
0.8917 High Similarity NPC244250
0.891 High Similarity NPC263384
0.891 High Similarity NPC472420
0.891 High Similarity NPC472422
0.891 High Similarity NPC472423
0.891 High Similarity NPC471676
0.891 High Similarity NPC474744
0.891 High Similarity NPC474772
0.891 High Similarity NPC474021
0.891 High Similarity NPC244577
0.891 High Similarity NPC289774
0.891 High Similarity NPC81474
0.891 High Similarity NPC209846
0.891 High Similarity NPC328740
0.891 High Similarity NPC477897
0.891 High Similarity NPC474023
0.8903 High Similarity NPC472628
0.8903 High Similarity NPC470461
0.8903 High Similarity NPC269420
0.8896 High Similarity NPC473077
0.8896 High Similarity NPC140120
0.8896 High Similarity NPC296998
0.8896 High Similarity NPC283234
0.8889 High Similarity NPC204088
0.8889 High Similarity NPC329215
0.8889 High Similarity NPC259007
0.8882 High Similarity NPC214236
0.8882 High Similarity NPC472402
0.8882 High Similarity NPC78332
0.8882 High Similarity NPC78803
0.8882 High Similarity NPC299080
0.8882 High Similarity NPC282636
0.8882 High Similarity NPC44947
0.8882 High Similarity NPC59739
0.8882 High Similarity NPC294863
0.8882 High Similarity NPC293852
0.8882 High Similarity NPC240306
0.8882 High Similarity NPC62840
0.8882 High Similarity NPC217083
0.8882 High Similarity NPC144499
0.8882 High Similarity NPC266725
0.8882 High Similarity NPC475106
0.8882 High Similarity NPC471520
0.8882 High Similarity NPC219861
0.8875 High Similarity NPC153342
0.8868 High Similarity NPC108831
0.8868 High Similarity NPC135391
0.8868 High Similarity NPC288084
0.8868 High Similarity NPC133671
0.8868 High Similarity NPC77672
0.8868 High Similarity NPC122809
0.8868 High Similarity NPC182634
0.8868 High Similarity NPC282390
0.8868 High Similarity NPC273843
0.8868 High Similarity NPC197304
0.8868 High Similarity NPC78263
0.8868 High Similarity NPC281137
0.8868 High Similarity NPC65504
0.8868 High Similarity NPC54802
0.8868 High Similarity NPC470606
0.8861 High Similarity NPC92395
0.8861 High Similarity NPC133392
0.8861 High Similarity NPC470681
0.8861 High Similarity NPC87404

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC172687 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9074 High Similarity NPD7804 Clinical (unspecified phase)
0.9013 High Similarity NPD4378 Clinical (unspecified phase)
0.8987 High Similarity NPD7075 Discontinued
0.8917 High Similarity NPD7096 Clinical (unspecified phase)
0.875 High Similarity NPD4381 Clinical (unspecified phase)
0.8726 High Similarity NPD4380 Phase 2
0.8645 High Similarity NPD7410 Clinical (unspecified phase)
0.8616 High Similarity NPD6801 Discontinued
0.8571 High Similarity NPD7251 Discontinued
0.8562 High Similarity NPD2393 Clinical (unspecified phase)
0.8521 High Similarity NPD7808 Phase 3
0.8512 High Similarity NPD6797 Phase 2
0.8509 High Similarity NPD8443 Clinical (unspecified phase)
0.8471 Intermediate Similarity NPD1512 Approved
0.8462 Intermediate Similarity NPD6799 Approved
0.8457 Intermediate Similarity NPD3882 Suspended
0.8395 Intermediate Similarity NPD3817 Phase 2
0.8393 Intermediate Similarity NPD7054 Approved
0.8385 Intermediate Similarity NPD1934 Approved
0.8375 Intermediate Similarity NPD6599 Discontinued
0.8344 Intermediate Similarity NPD1511 Approved
0.8343 Intermediate Similarity NPD7472 Approved
0.8343 Intermediate Similarity NPD7074 Phase 3
0.8333 Intermediate Similarity NPD3818 Discontinued
0.8333 Intermediate Similarity NPD2801 Approved
0.8333 Intermediate Similarity NPD7819 Suspended
0.8323 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.8323 Intermediate Similarity NPD6166 Phase 2
0.8323 Intermediate Similarity NPD7411 Suspended
0.8323 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.8312 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.8312 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.8304 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.8293 Intermediate Similarity NPD3749 Approved
0.8258 Intermediate Similarity NPD1549 Phase 2
0.8246 Intermediate Similarity NPD6559 Discontinued
0.8205 Intermediate Similarity NPD2800 Approved
0.8193 Intermediate Similarity NPD5494 Approved
0.8187 Intermediate Similarity NPD5403 Approved
0.8182 Intermediate Similarity NPD1510 Phase 2
0.8153 Intermediate Similarity NPD3750 Approved
0.8129 Intermediate Similarity NPD2796 Approved
0.8121 Intermediate Similarity NPD7768 Phase 2
0.8107 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.8063 Intermediate Similarity NPD5401 Approved
0.8061 Intermediate Similarity NPD5402 Approved
0.8039 Intermediate Similarity NPD1240 Approved
0.8036 Intermediate Similarity NPD6959 Discontinued
0.8034 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7975 Intermediate Similarity NPD1243 Approved
0.7953 Intermediate Similarity NPD7473 Discontinued
0.7935 Intermediate Similarity NPD1607 Approved
0.7917 Intermediate Similarity NPD919 Approved
0.7904 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7882 Intermediate Similarity NPD6232 Discontinued
0.7853 Intermediate Similarity NPD920 Approved
0.784 Intermediate Similarity NPD2533 Approved
0.784 Intermediate Similarity NPD2532 Approved
0.784 Intermediate Similarity NPD2534 Approved
0.7834 Intermediate Similarity NPD3748 Approved
0.7824 Intermediate Similarity NPD1247 Approved
0.7803 Intermediate Similarity NPD3751 Discontinued
0.7799 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7784 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7778 Intermediate Similarity NPD3787 Discontinued
0.776 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7759 Intermediate Similarity NPD5844 Phase 1
0.775 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7736 Intermediate Similarity NPD2344 Approved
0.773 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7722 Intermediate Similarity NPD2799 Discontinued
0.7716 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7679 Intermediate Similarity NPD1465 Phase 2
0.7677 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7677 Intermediate Similarity NPD2313 Discontinued
0.7673 Intermediate Similarity NPD2935 Discontinued
0.7673 Intermediate Similarity NPD6100 Approved
0.7673 Intermediate Similarity NPD6099 Approved
0.7672 Intermediate Similarity NPD7584 Approved
0.767 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7654 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7647 Intermediate Similarity NPD2798 Approved
0.763 Intermediate Similarity NPD3926 Phase 2
0.763 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7606 Intermediate Similarity NPD7435 Discontinued
0.7595 Intermediate Similarity NPD6651 Approved
0.7593 Intermediate Similarity NPD4628 Phase 3
0.7593 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7593 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7564 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7562 Intermediate Similarity NPD1551 Phase 2
0.7557 Intermediate Similarity NPD7286 Phase 2
0.7546 Intermediate Similarity NPD2309 Approved
0.7545 Intermediate Similarity NPD3226 Approved
0.7545 Intermediate Similarity NPD7458 Discontinued
0.7542 Intermediate Similarity NPD8312 Approved
0.7542 Intermediate Similarity NPD8313 Approved
0.754 Intermediate Similarity NPD6782 Approved
0.754 Intermediate Similarity NPD6777 Approved
0.754 Intermediate Similarity NPD6779 Approved
0.754 Intermediate Similarity NPD6780 Approved
0.754 Intermediate Similarity NPD6776 Approved
0.754 Intermediate Similarity NPD6781 Approved
0.754 Intermediate Similarity NPD6778 Approved
0.7532 Intermediate Similarity NPD6355 Discontinued
0.753 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7516 Intermediate Similarity NPD2346 Discontinued
0.7514 Intermediate Similarity NPD8434 Phase 2
0.7486 Intermediate Similarity NPD2403 Approved
0.7472 Intermediate Similarity NPD5953 Discontinued
0.7471 Intermediate Similarity NPD8455 Phase 2
0.7459 Intermediate Similarity NPD4360 Phase 2
0.7459 Intermediate Similarity NPD4363 Phase 3
0.7455 Intermediate Similarity NPD7390 Discontinued
0.7452 Intermediate Similarity NPD3268 Approved
0.7436 Intermediate Similarity NPD4908 Phase 1
0.7421 Intermediate Similarity NPD7698 Approved
0.7421 Intermediate Similarity NPD7697 Approved
0.7421 Intermediate Similarity NPD7696 Phase 3
0.7414 Intermediate Similarity NPD7199 Phase 2
0.7391 Intermediate Similarity NPD7033 Discontinued
0.7391 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7382 Intermediate Similarity NPD7870 Phase 2
0.7382 Intermediate Similarity NPD7871 Phase 2
0.7371 Intermediate Similarity NPD5710 Approved
0.7371 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7371 Intermediate Similarity NPD7874 Approved
0.7371 Intermediate Similarity NPD5711 Approved
0.7365 Intermediate Similarity NPD5049 Phase 3
0.7358 Intermediate Similarity NPD943 Approved
0.7358 Intermediate Similarity NPD7701 Phase 2
0.7355 Intermediate Similarity NPD1203 Approved
0.7355 Intermediate Similarity NPD2797 Approved
0.7349 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7342 Intermediate Similarity NPD6798 Discontinued
0.7337 Intermediate Similarity NPD4287 Approved
0.7337 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7333 Intermediate Similarity NPD2354 Approved
0.7326 Intermediate Similarity NPD4361 Phase 2
0.7326 Intermediate Similarity NPD4362 Clinical (unspecified phase)
0.7325 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7322 Intermediate Similarity NPD8150 Discontinued
0.7312 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7312 Intermediate Similarity NPD5124 Phase 1
0.7312 Intermediate Similarity NPD1933 Approved
0.7303 Intermediate Similarity NPD7228 Approved
0.7301 Intermediate Similarity NPD1471 Phase 3
0.7299 Intermediate Similarity NPD6234 Discontinued
0.7288 Intermediate Similarity NPD7784 Clinical (unspecified phase)
0.7284 Intermediate Similarity NPD4308 Phase 3
0.7278 Intermediate Similarity NPD7095 Approved
0.7278 Intermediate Similarity NPD4625 Phase 3
0.7273 Intermediate Similarity NPD6535 Approved
0.7273 Intermediate Similarity NPD6534 Approved
0.7273 Intermediate Similarity NPD7229 Phase 3
0.7268 Intermediate Similarity NPD7585 Approved
0.7261 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7251 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.725 Intermediate Similarity NPD4060 Phase 1
0.7249 Intermediate Similarity NPD7700 Phase 2
0.7249 Intermediate Similarity NPD7699 Phase 2
0.7245 Intermediate Similarity NPD7801 Approved
0.7245 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7245 Intermediate Similarity NPD7783 Phase 2
0.7238 Intermediate Similarity NPD7685 Pre-registration
0.7233 Intermediate Similarity NPD3764 Approved
0.7231 Intermediate Similarity NPD8151 Discontinued
0.7225 Intermediate Similarity NPD4288 Approved
0.7216 Intermediate Similarity NPD7583 Approved
0.7215 Intermediate Similarity NPD6832 Phase 2
0.7209 Intermediate Similarity NPD37 Approved
0.7208 Intermediate Similarity NPD422 Phase 1
0.7208 Intermediate Similarity NPD1610 Phase 2
0.7202 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7202 Intermediate Similarity NPD8320 Phase 1
0.7202 Intermediate Similarity NPD8319 Approved
0.7188 Intermediate Similarity NPD6233 Phase 2
0.7188 Intermediate Similarity NPD6823 Phase 2
0.7184 Intermediate Similarity NPD4966 Approved
0.7184 Intermediate Similarity NPD4967 Phase 2
0.7184 Intermediate Similarity NPD4965 Approved
0.7179 Intermediate Similarity NPD3225 Approved
0.7178 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7173 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7161 Intermediate Similarity NPD9717 Approved
0.7152 Intermediate Similarity NPD2424 Discontinued
0.7143 Intermediate Similarity NPD1613 Approved
0.7143 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7134 Intermediate Similarity NPD3266 Approved
0.7134 Intermediate Similarity NPD3267 Approved
0.7108 Intermediate Similarity NPD2654 Approved
0.7099 Intermediate Similarity NPD447 Suspended
0.7097 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7093 Intermediate Similarity NPD6585 Discontinued
0.7091 Intermediate Similarity NPD2353 Approved
0.7091 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7091 Intermediate Similarity NPD2355 Clinical (unspecified phase)
0.7059 Intermediate Similarity NPD1548 Phase 1
0.7051 Intermediate Similarity NPD1608 Approved
0.7037 Intermediate Similarity NPD4307 Phase 2

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data